TNDM
Tandem Diabetes Care Inc
15.70$
+3.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 85.2% | 85.5% | 81.9% | 67.3% | 91.1% | 84.7% | 88.9% | 89.7% | 80.7% | 78.5% | 74.9% | 70.2% | |
| 29.3% | 34.4% | 39.8% | 14.4% | 20.3% | 15.7% | 13.2% | 7.9% | 16.4% | 6.2% | 7.2% | 10.3% | |
| 63.2% | 56.8% | 47.6% | 14.9% | 62.5% | 54.1% | 67.7% | 68.9% | 58.6% | 49.1% | 45.3% | 33.2% | |
| 7.2% | 11.2% | 9.9% | 21.8% | 17.1% | 14.3% | 11.5% | 12.2% | 10.9% | 11.1% | 11.8% | 18.8% | |
| 11.2% | 14.0% | 18.9% | 28.3% | 9.6% | 15.0% | 8.9% | 7.6% | 10.6% | 16.6% | 15.5% | 14.6% | |
| 11.8% | 12.4% | 16.4% | 20.6% | 8.3% | 10.1% | 7.0% | 5.6% | 6.5% | – | – | – | |
| 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 2.3% | 1.7% | 1.6% | 1.5% | 0.5% | 0.2% | 1.2% | 0.7% | 0.4% | 0.3% | 0.1% | 1.3% | |
| 48.7% | 49.3% | 105.3% | 130.6% | 36.4% | 40.2% | 48.9% | 52.1% | 58.2% | 67.1% | 72.8% | 82.4% | |
| 17.0% | 21.2% | 28.0% | 37.8% | 32.1% | 30.5% | 14.5% | 14.6% | 15.7% | 20.5% | 25.5% | 27.5% | |
| 27.7% | 23.4% | 70.3% | 80.3% | – | 1.9% | 1.3% | 1.0% | 1.2% | 1.8% | 6.1% | 2.2% | |
| 13.7% | 15.3% | 17.2% | 23.6% | 3.3% | 5.4% | 2.5% | 3.1% | 5.3% | 5.2% | 4.6% | 5.3% | |
| 27.7% | 23.7% | 70.3% | 80.3% | – | – | 28.3% | 31.1% | 26.9% | 29.9% | 31.9% | 35.2% | |
| 51.3% | 50.7% | -5.3% | -30.6% | 63.6% | 59.8% | 51.1% | 47.9% | 41.8% | 32.9% | 27.2% | 17.6% | |
| -233.6% | -256.7% | -360.0% | -500.9% | -290.9% | -191.6% | -92.0% | -70.1% | -69.3% | -99.9% | -108.3% | -142.2% | |
| 2.2% | 2.3% | 2.7% | 6.0% | 23.3% | 17.9% | 8.5% | 7.1% | 6.1% | 6.8% | 6.8% | 7.6% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.